leadf
logo-loader
viewAggreko

Aggreko climbs on Credit Suisse upgrade to ‘outperform’

The upgrade was underpinned by a US$200mln supply contract awarded by the Tokyo 2020 Olympic games

Aggreko - Credit Suisse upgrades Aggreko to ‘outperform’
The investment bank also upped the price target to 905p to 750p

Aggreko PLC (LON:AGK) was upgraded to ‘outperform’ from ‘neutral’ by Credit Suisse, on the back of the FTSE 250-listed company’s profitability goals underpinned by a major contract at Tokyo 2020.

The investment bank also upped the price target to 905p to 750p in its note on Tuesday, also citing benefits from the Olympics supply contract, valued at US$200mln.

The Glasgow-based group, which supplies equipment for temporary power generation and temperature control, previously said it will deliver mid-teens return on capital employed (ROCE) next year.

Credit Suisse based the re-rating on the cost-reduction programme set by management as well as a number of initiatives aimed at improving all levels of ROCE, which is forecast to rise from 10.3% in 2018 to 15.9% in 2023.

Shares were up 1% to 812.8p on Tuesday at noon.

Quick facts: Aggreko

Price: 364.8 GBX

LSE:AGK
Market: LSE
Market Cap: £9.41 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

IXICO plays 'pivotal role' after announcing £2m extension to Huntington's...

IXICO PLC's (LON:IXI) Lammert Albers talks to Proactive London about the £2m extension to a contract to provide additional imaging services for a pivotal Huntington's disease (HD) study. Albers describes this as a 'strong suit' having started very early and now carrying out a Phase III...

1 hour, 43 minutes ago

2 min read